Notice of Special Interest: Administrative Supplement for Research on Bioethical Issues (Admin Supp Clinical Trial Optional) NOT-OD-20-038

Key Dates

Related Announcements

PA-19-217

PA-18-591

NOT-OD-21-020

Issued by

Office of The Director, National Institutes of Health (OD)

National Heart, Lung, and Blood Institute (NHLBI)

National Human Genome Research Institute (NHGRI)

National Institute on Aging (NIA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute on Deafness and Other Communication Disorders (NIDCD)

National Institute of Dental and Craniofacial Research (NIDCR)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute on Drug Abuse (NIDA)

National Institute of Environmental Health Sciences (NIEHS)

National Institute of Mental Health (NIMH)

National Institute of Neurological Disorders and Stroke (NINDS)

National Institute of Nursing Research (NINR)

National Institute on Minority Health and Health Disparities (NIMHD)

Fogarty International Center (FIC)

National Center for Complementary and Integrative Health (NCCIH)

National Center for Advancing Translational Sciences (NCATS)

Sexual and Gender Minority Research Office (SGMRO)

National Cancer Institute (NCI)

All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.

Office of Behavioral and Social Sciences Research (OBSSR)

Office of Research on Women's Health (ORWH)

Tribal Health Research Office (THRO)

National Library of Medicine (NLM) - New participating organization as of 03/06/2020 for due dates on/after 03/06/2020

National Eye Institute ( NEI ) - New participating organization as of 03/09/2020 for due dates on/after 03/09/2020

Purpose

The NIH Office of Science Policy (OSP) within the Office of the Director (OD) announces the availability of administrative supplements to support research on bioethical issues to develop an evidence base that may inform future policy directions. Applicants may propose to supplement parent awards focused on bioethics or to add a component related to bioethics to a parent award in which bioethics was not the focus. Note that applications must be within the general scope of the parent award.

All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers: the Office for Behavioral and Social Sciences Research (OBSSR), the Office for Research on Women’s Health (ORWH), the Sexual and Gender Minority Research Office (SGMRO), and the Tribal Health Research Office (THRO).

Background

Ethical considerations are intrinsic to the responsible conduct of biomedical research and the translation of scientific and technological advances into practice. Research into bioethical issues can provide an evidentiary basis to guide conduct, content, and/or application of the biomedical and behavioral sciences and their associated policies, which becomes of increasing importance as science and societal views continue to evolve. Ethical questions and challenges are interlinked with many of NIH’s general areas of scientific priority, such as responding to public health needs (e.g., the opioid crisis, desire for precision medicine interventions) and emerging scientific opportunities (e.g., new data sharing infrastructure, innovative technologies). The investment in and the integration of bioethics-related research and policy demonstrates NIH’s commitment to safeguarding the integrity of the research that it conducts and supports, which, in turn, facilitates public participation and trust in the research enterprise.

This administrative supplement funding opportunity announcement will provide an opportunity for NIH-supported researchers to support research on bioethical issues to develop an evidence base that may inform future policy directions. Applicants may propose to supplement parent awards focused on bioethics or to add a component related to bioethics to a parent award in which bioethics was not the focus.

Specific Areas of Research Interest

The NIH seeks to fund research on ethical considerations related to biomedical research. Applications for projects that do not propose a research question or research aim specific to a bioethical issue that may inform future policy directions (e.g. applications that propose only to support training or educational activities that do not involve investigation of a research question) will not be considered. Issues of interest fall within the scope of research supported by the NIH but may be beyond the focus of any one Institute or Center. Applications should propose research on topics that can provide an evidence base that may inform future policy directions, which includes current or future NIH-issued policies, other federal policies, laws, and regulations, as well as policies governing the practice of research or medicine. Overarching areas of research interest may include but are not limited to:

• New and emerging technology development and use, such as: gene editing; organoids; artificial intelligence; machine learning; brain implants and modulation; digital health; consumer-generated data; synthetic biology
• Clinical and non-clinical data sharing; big data and data science analytics; integration of data for research, including clinical, research, environment, social media, participant/patient provided, and other data types; biases in datasets and algorithms
• Precision and personalized medicine
• Personal, institutional, and research privacy and security
• Learning Healthcare System; interface of clinical research and clinical care; pragmatic trials; real-world data
• Crowdsourcing, citizen science, and DIY biomedical research
• Participant driven, directed, or sponsored clinical research
• Patient/participant representation in research oversight and study design, including appropriate return of research results and incidental findings
• Special and vulnerable population research, including pediatric, palliative care, emergency, disaster, and pandemic research
• Individual or community health, treatment, and/or research disparities; accessing and sharing benefits of research; post-study obligations
• Issues related to the inclusion of Tribal and American Indian/Alaska Native populations
• Issues related to the inclusion of populations underrepresented in research, including issues related to inclusion of and research with sexual and gender minorities
• Current and emerging regulatory and policy environments, including NIH policy
• Innovative study design, conduct, management, and oversight, including methods for obtaining and documenting informed consent; virtual clinical trials
• International research including research in resource-constrained settings, transnational research, and research in low and middle income countries
• Research on stigmatized conditions
• Historical analyses of bioethics issues
• Novel approaches for developing, enhancing, and measuring effectiveness of, bioethics infrastructure and training
• New means for enhancing and assessing the scientific workforce, including policies to promote scientific workforce diversity and inclusion and promote a safe and inclusive research environment

In addition to overarching areas of interest, individual NIH Institutes, Centers, and Offices have indicated the following specific areas of research interest:

FIC

The Fogarty International Center (FIC) is interested in research on ethical issues relevant to low- and middle-income countries, in particular, studies conducted by investigators in these countries.

All of Us Research Program

The All of Us Research Program is interested in applications that address topics relevant to its core mission. Please note that at this time, recontact of All of Us Research Program participants is not possible. The program is in the process of developing the requisite policies and technical infrastructure to support ancillary studies, including ELSI research, and will notify researchers when these capabilities become available.

NCI

The National Cancer Institute (NCI) is interested in bioethics issues relevant to cancer research and care, such as issues raised in cancer clinical trials, cohort studies, cancer prevention studies, cancer centers, prospective biobanking, or projects using existing samples/tissues. Bioethical issues of interest include but are not limited to issues raised by new therapies/technologies; issues raised by the use of ancestry markers vs. ethnicity/race in research and treatment; innovative methods for recruitment and retention of participants who are underserved, hard to reach, or otherwise underrepresented in research; participant, community, or patient engagement; return of research results; participant and patient perception and comprehension; effective communication (including patient-provider and to/within families); increasing access to care for populations with cancer disparities. Additional issues may be found here: https://epi.grants.cancer.gov/bioethics-cancer-research.html. NCI encourages investigators to contact the parent grant program officer to address any budgetary issues prior to submitting a supplement application

NHGRI

The National Human Genome Research Institute (NHGRI) is interested in applications which investigate and address bioethical issues related to the use of genetics and genomics in research, clinical medicine and healthcare, and society. NHGRI supports studies into specific conditions or diseases only if the proposed work will produce knowledge that is generalizable or transferable to other genetic conditions. Research on the implications of new and emerging genomic technologies and novel uses of existing technologies are particularly encouraged. Examples could include, but are not limited to: the use of polygenic risk scores in diverse ancestral populations, synthetic biology and the application of artificial intelligence and/or machine learning to genomic data.

NHLBI

The National Heart, Lung, and Blood Institute (NHLBI) is interested in research on bioethics issues relevant to its Strategic Vision (https://www.nhlbi.nih.gov/about/strategic-vision), and its focus on heart, lung, blood, and sleep conditions. Specific examples include, but are not limited to

• The return of research results (e.g., genomic, -omic, environmental) with context to participants and communities, such as environmental toxins that may impact community health, the handoff between research and clinical care, and providing genetic counseling at large scales
• Issues related to clinical trials, including adaptive clinical trial designs, usual care arms, or other novel designs
• Bioethical questions related to implementation science research
• Waivers of informed consent, exceptions from informed consent, or obtaining consent from surrogates
• Ethics of cardiopulmonary support
• Novel and emerging technologies, such as machine learning bias or algorithm overreach and physician autonomy
• Privacy and confidentiality (especially in large datasets), such as artificial intelligence applied to imaging data or concerns that may arise from multi-omics profiles
• The impact of NIH policy changes, such as updates to the management of genomic summary results
• Issues related to working with understudied or vulnerable populations or creating culturally-appropriate messaging

Investigators are encouraged to contact NHLBI staff to discuss their ideas

NCATS

The National Center for Advancing Translational Sciences (NCATS) is interested in research on ethical issues that cross disease domains and span the translational research spectrum. NCATS encourages collaboration between translational researchers and bioethics researchers on projects addressing ethical challenges in moving discoveries from laboratory, clinic, and community into interventions that improve health.

Note concerning the Award Project Period: Supplement project and budget periods are limited to the remaining active budget period that started in FY20 for the existing parent award. To be eligible, the parent award must be active (i.e. not be in an extension period), and the activities proposed in the supplement must be accomplished within the remaining active budget period that started in FY20 for the existing parent award. The earliest anticipated start date is July 1, 2020.

NIMHD

The National Institute on Minority Health and Health Disparities (NIMHD) is interested in supporting research projects on the ethical, legal, and social implications of research participation and/or health care for racial/ethnic minority or other health disparity populations. Areas of interest to NIMHD include but are not limited to studies that seek to understand or address cultural preferences; values and norms to ensure ethical and equitable conduct of research and delivery of health care; ethical integration of social and biomedical sciences (e.g., social epigenomics and incorporation of social determinants into the health care system); and mitigating stigmatization, group harms, and unintended social implications of research.

NIAAA

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) is interested in bioethics applications that address topics relevant to its mission and research priorities as provided in its strategic plan. For information, please see: https://www.niaaa.nih.gov/strategic-plan

NIAID

NIAID is interested in supporting supplemental projects that focus on ethical issues relevant to domestic and international collaborative research on HIV/AIDS or its co-morbidities (TB, malaria, hepatitis, sexually transmitted infections), other infectious diseases, immunologic and allergic diseases; ethics of clinical trials and implementation science; other ethical issues relevant to NIAID's scientific mission. Applications may include conceptual work in bioethics, or empirical work gathering and analyzing data relevant to ethical issues in research, or a combination of the two. For empirical projects, data collection may include quantitative or qualitative methods, or both. Although not intended to be an exhaustive list, of particular interest are projects on

• Ethical issues in research involving adolescents and young adults
• Ethical issues in research on preventing, treating, or curing HIV
• Ethical, legal and policy issues at the intersections of public health surveillance, care delivery, and research
• Ethics of research involving child-bearing age and pregnant women

Applications addressing empirical research on informed consent are not of interest

NIAMS

The mission of The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is to support research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases; the training of basic and clinical scientists to carry out this research; and the dissemination of information on research progress in these diseases. NIAMS also conducts and supports basic research on the normal structure and function of bones, joints, muscles, and skin. Clinical research areas include rheumatology, orthopedics, dermatology, metabolic bone diseases, heritable disorders of bone and cartilage, inherited and inflammatory muscle diseases, and sports and rehabilitation medicine. NIAMS is interested in bioethics topics relevant to its core mission.

NIBIB

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is interested in bioethics research relevant to its mission to support the development of innovative technologies in bioimaging and bioengineering. Areas of particular interest to NIBIB include, but are not limited to, ethical issues related to: artificial intelligence and machine learning; digital health and wearable/implantable technologies; clinical decision support systems (for healthcare professionals, caregivers, and/or patients); data sharing, privacy, and security; synthetic biological systems; neuromodulation technologies; health disparities and inclusion in biomedical research. Investigators are strongly encouraged to contact NIBIB staff to discuss their ideas. For more information on areas of interest to the NIBIB, please visit: https://www.nibib.nih.gov/research-funding

NIDDK

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is interested in applications that address topics relevant to its core mission. For more information, please see: NIDDK Research Areas

NCCIH

The National Center for Complementary and Integrative Health (NCCIH) is interested in bioethics applications that address topics relevant to its mission and research priorities as provided in its strategic plan. For information, please see: https://nccih.nih.gov/about/plans

NICHD

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is interested in bioethical issues relevant to research involving children, pregnant women, and people with disabilities. Research in the fields of developmental biology, reproductive health, pediatrics, population health, and medical rehabilitation, research that addresses health disparities and improves prevention efforts among the populations served by NICHD, as well as areas identified as high-priority research areas to the institute are of particular interest. See https://www.nichd.nih.gov/grants-contracts/research-areas/priorities for the current research priorities for the institute and in https://www.nichd.nih.gov/about/org/strategicplan regarding future themes for the Institute.

NIDCD

The National Institute on Deafness and Other Communications Disorders (NIDCD) is interested in applications that address topics in the areas of hearing, balance, taste, smell, voice, speech, and language. For more information, please see: NIDCD Strategic Plan

NIDCR

The National Institute of Dental and Craniofacial Research (NIDCR) is interested in applications that propose bioethics research relevant to dental, oral, and craniofacial health. For more information, please see: https://www.nidcr.nih.gov/about-us/mission. In addition to the overarching priority areas of this notice as related to dental, oral, and craniofacial health, the NIDCR is also interested in:

• Return of incidental findings about overall health from clinical and non-clinical data (e.g., genome-wide omics data) produced in studies that focus on dental, oral and craniofacial phenotypes
• Privacy, confidentiality, data re-use and other ethical issues with clinical and non-clinical data, particularly large scale facial image data and omics data

NIDA

The National Institute on Drug Abuse (NIDA) is interested in bioethics applications that address topics relevant to its mission and research priorities as provided in its strategic plan, including research involving pregnant women using substances. For more information, please see: https://www.drugabuse.gov/about-nida/2016-2020-nida-strategic-plan

NINDS

The National Institute of Neurological Disorders and Stroke (NINDS) is interested in research on bioethical and neuroethical questions relevant to its mission to seek fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease. In addition to the general areas of interest listed above, areas of interest specific to NINDS include but are not limited to the ethical implications of: aspects of neuroscience research with human participants, such as differing stakeholder views on trial design, return of research results to participants, patient consent-related issues, or therapeutic misconception (including for rare diseases); research with brain organoids or ex vivo human brain tissue; collecting and sharing human brain data, such as de-identification, privacy, and re-use practices; the development and use of neuromodulation and neuroimaging technologies, such as device maintenance, data security, and intended and unintended uses of these technologies; predictive/diagnostic research related to brain disorders; and advances in neural recording and/or neuromodulation specifically for use in children. Additional information about the NINDS mission may be found here: http://www.ninds.nih.gov/about_ninds/mission.htm. Note that applications must consider bioethical and/or neuroethical questions and be within the general scope of the parent award. Also, NINDS will not consider supplement applications that include basic research activities or research with vertebrate animals.

NINR

NINR is interested in studies examining the bioethical issues related to end of life and palliative care (EOLPC) research that consider (including but not limited to):

• The EOLPC needs of individuals with serious, advanced illness, particularly in vulnerable populations such as: children, frail elderly, and individuals with limited decision-making capacity.
• Prioritization of patient preferences, beliefs, and values with respect to treatment and/or end of life decision making.
• The needs/challenges of families, caregivers, and proxy decision makers of individuals with serious, advanced illness.
• Disparities in access to EOLPC for individuals across settings (urban, rural, remote), including differences among socioeconomic, racial/ethnic and geographic sub-populations.

Because of the complex, multi-factorial nature of this issue, multi-disciplinary teams are highly encouraged

NIEHS

The National Institute of Environmental Health Sciences (NIEHS) is interested in bioethics applications that address topics relevant to its mission and research priorities as provided in its strategic plan. For information, please see: https://www.niehs.nih.gov/about/strategicplan/index.cfm

NIA

The National Institute on Aging (NIA) is interested in applications that address topics relevant to its core mission. For more information, please see: https://www.nia.nih.gov/about/mission

NIMH

The National Institute of Mental Health (NIMH) is interested in bioethics applications that address topics relevant to its mission and research priorities as provided in its strategic plan. For information, please see: https://www.nimh.nih.gov/about/strategic-planning-reports/index.shtml

NLM
The National Library of Medicine (NLM) is interested in bioethics applications that address topics relevant to its mission and research priorities as provided in its strategic plan. For information, please see: https://www.nlm.nih.gov/pubs/plan/lrp17/NLM_StrategicReport2017_2027.html.

Office of Research on Women’s Health

The Office of Research on Women’s Health (ORWH) focuses on research that is relevant to the health of women and is interested in research on bioethics issues that intersect with the goals, objectives, and guiding principles of the trans-NIH Strategic Plan for Women’s Health Research (https://orwh.od.nih.gov/about/trans-nih-strategic-plan-womens-health-research). Specific examples include, but are not limited to:

• Ethical, legal, and social implications of sex and/or gender differences research across the lifespan; and the ethics of the consideration of sex/gender and intersectionality in basic, translational, and clinical research
• The inclusion and/or exclusion of understudied, underrepresented, and underreported populations of women in research (i.e. pregnant and lactating women, incarcerated women, young girls, women of color, women with health disparities, sex and gender minority women, women with disabilities, and women living in rural areas); and their retention in research
• Ethical issues governing the retainment and advancement of women in biomedical careers (i.e. power dynamics and/or differentials, gender harassment, hiring, promotion and tenure); and issues related to women participating in team science and conducting interdisciplinary and/or trans-disciplinary research.
• Bioethical issues derived from data generated in research and development (R&D) of drugs, medical devices, and emerging technologies, along with health screenings (i.e. mammograms, Pap-smears, newborn screening, EKG)
• Societal implications, such as stigma based on gender, related to sex and/or gender bias or considerations in the development and use of novel and emerging technologies (i.e. artificial intelligence, machine learning, multi-accuracy auditing, digital/mobile health, social media tools)
• Sex/gender neuroethics and ethics related to sex and gender considerations in genomic research and precision medicine
• Ethical issues around provider-patient interactions/relationships and family caregiving related to its impact on women’s health and well-being

Scope of Support

The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

The Office of the Director intends to commit at least $2,000,000 in FY 2020 to fund approximately 10 awards

Application and Submission Information

Applications for this initiative must be submitted using the following opportunity or its subsequent reissued equivalent.

• PA-18-591 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)

All instructions in the SF424 (R&R) Application Guide and PA-18-591 must be followed, with the following additions:

• Application Due Date(s) March 20, 2020, by 5:00 PM local time of applicant organization.
• For funding consideration, applicants must include NOT-OD-20-038 (without quotation marks) in the Agency Routing Identifier field (box 4B) of the SF424 R&R form. Applications without this information in box 4B will not be considered for this initiative.
• Application budget cannot exceed a maximum direct cost of $100,000. In addition to the direct cost, applicable F&A (indirect) costs can also be requested.
• Requests may be for one year of support only.
• The Research Strategy section of the application is limited to 6 pages.
• All criteria for review in Section V. Application Review Criteria in PA-18-591 will be followed, except that the following criteria will be used instead of the criteria provided for Overall Impact:
• NIH staff will consider the ability of the proposed supplement activities to increase or preserve the parent award’s overall impact within the original scope of award as appropriate:
  • Will the administrative supplement increase or preserve the likelihood for the project to exert an influence on the bioethics-related policy of the research field(s) involved?
  • Will the administrative supplement provide an evidence base that may inform future policy directions?
  • Does the administrative supplement address a bioethical issue that is pressing, recurring, and/or emerging in biomedical research?
  • Are the overall strategy, methodology, and analyses proposed in the supplement application well-reasoned and appropriate to accomplish the proposed research in a one-year period?
• The process for Streamlined Submissions using the eRA Commons cannot be used for this initiative.
• Applicant organizations may submit more than one application, provided that each is sufficiently distinct from any other administrative supplement currently under consideration by the awarding NIH Institute or Center. Only one application per parent award may be submitted.
• Applicants are strongly encouraged to notify the program contact at the Institute supporting the parent award that a request has been submitted in response to this FOA in order to facilitate efficient processing of the request.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Wendy Weber, N.D., Ph.D., M.P.H.
National Center for Complementary and Integrative Health (NCCIH)
Telephone: 301-402-1272
Email: weberwj@mail.nih.gov

Kristina McLinden, PhD
National Institute on Aging
Telephone: 301-827-2563
Email: mclindenka@nih.gov

Shari Feirman, Ph.D.

Office of Science Policy/Office of the Director (OSP/OD)
Telephone: 301-435-6350
Email: shari.feirman@nih.gov

Nicole Lockhart, Ph.D.
National Human Genome Research Institute (NHGRI)
Telephone: 301-480-2493
Email: lockhani@mail.nih.go

Tammara Jenkins, MSN, RN, PCNS-BC
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-435-6837
Email: tjenkins@mail.nih.gov

Khara Ramos, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-594-2614
Email: khara.ramos@nih.gov

Mollie Minear, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0448
Email: mollie.minear@nih.gov

Barbara Sina, Ph.D.
Fogarty International Center (FIC)
Telephone: 301-402-9467
Email: sinab@mail.nih.gov

Elaine Collier, M.D.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-435-0794
Email: colliere@mail.nih.gov

Charlisse Caga-anan, J.D.
National Cancer Institute (NCI)
Telephone: 240-276-6738
Email: charlisse.caga-anan@nih.gov

Pamela Wernett, Ph.D.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-827-5391
Email: wernettpj@mail.nih.gov

Joana Roe
National Institute of Allergies and Infectious Disease (NIAID)
Telephone: 240-627-3213
Email: Joana.Roe@nih.gov

Marisol Espinoza-Pintucci, Ph.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-827-6959
Email: marisol.espinoza-pintucci@nih.gov

Todd Merchak
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Telephone: 301-496-8592
Email: merchakt@mail.nih.gov

Trinh Ly, M.D.
National Institute of Deafness and Other Communication Disorders (NIDCD)
Telephone: 301-435-4085
Email: trinh.ly@nih.gov

Leslie Frieden, Ph.D.
National Institute of Dental and Craniofacial Research (NIDCR)
Telephone: 301-496-4263
Email: leslie.frieden@nih.go

Aynur Unalp-Arida, MD, MSc, PhD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-8879
Email: aynur.unalp-arida@nih.go

Ruben Baler, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-480-2733
Email: baler@nida.nih.gov

Nancy Jones, Ph.D., M.A.
National Institute on Minority and Health Disparities (NIMHD)
Telephone: 301-594-8945
Email: jonesna@nimhd.nih.gov

Lynn Adams, Ph.D.
National Institute of Nursing Research (NINR)
Telephone: 301-594-8911
Email: adamsls@mail.nih.gov

Jamie White, M.S.
Office of Research on Women’s Health/Office of the Director (ORWH/OD)
Telephone: 301-496-9200
Email: Jamie.white@nih.gov

Subhashini Chandrasekharan, Ph.D.
All of Us Research Program/Office of the Director (AoURP/OD)
Email: subhashini.chandrasekharan@nih.go

Lindsey Martin, PhD
National Institute of Environmental Health Sciences
Telephone: 984.287.4036
Email: lindsey.martin@nih.gov

James Churchill, Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 301-443-3621
Email: churchillj@mail.nih.gov

Wendy Weber, ND, PhD, MPH
National Center for Complementary and Integrative Health (NCCIH)
Telephone: 301-402-1272
Email: weberwj@mail.nih.gov

Peer Review Contact(s)

Not Applicable

Financial/Grants Management Contact(s)

Shelley Carow
National Center for Complementary and Integrative Health (NCCIH)
Telephone: 301-594-3788
Email: carows@mail.nih.gov

Jeff Ball
National Institute on Aging
Telephone: 301-403-7736
Email: ballj@nia.nih.gov

Bryan Clark, MBA
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-435-6975
Email: clarkb1@mail.nih.gov

Chief Grants Management Officer
National Institute of Neurological Disorders and Stroke (NINDS)
Email: ChiefGrantsManagementOfficer@ninds.nih.gov

Monique Day, Ph.D.
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Telephone: 301-451-4797
Email: Monique.day@nih.gov

Bruce Butrum
Fogarty International Center (FIC)
Telephone: 301-496-2075
Email: butrumb@mail.nih.gov

Tawana McKeither
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-9238
Email: tawana.mckeither@nih.gov

Harvey Kincaid
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-435-0850
Email: harvey.kincaid@nih.gov

Crystal Wolfrey
National Cancer Institute (NCI)
Telephone: 240-276-6277
Email: wolfreyc@gab.nci.nih.gov

Deanna Ingersoll
National Human Genome Research Institute (NHGRI)
Telephone: 301-435-7858
Email: Deanna.Ingersoll@nih.gov

Judy Fox
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-443-4704
Email: jfox@mail.nih.gov

Dhana Khurana
National Institute of Allergies and Infectious Disease (NIAID)
Telephone: 240-669-2966
Email: Vandhana.Khurana@nih.gov

Leslie Littlejohn
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-594-5055
Email: Leslie.Littlejohn@nih.gov

Christopher Myers
National Institute on Deafness and Other Communication Disorders (NIDCD)
Telephone: 301-435-0713
Email: myersc@mail.nih.gov

Diana Rutberg, M.B.A.
National Institute of Dental and Craniofacial Research (NIDCR)
Telephone: 301-594-4798
Email: rutbergd@mail.nih.gov

Pamela G. Fleming
National Institute on Drug Abuse (NIDA)
Telephone: 301-480-1159
Email: pfleming@nida.nih.gov

Priscilla Grant, JD
National Institute on Minority Health and Health Disparities (NIMHD)
Telephone: 301-594-8412
Email: pg38h@nih.gov

Ronald Wertz
National Institute of Nursing Research (NINR)
Telephone: (301) 594-2807
Email: wertzr@mail.nih.gov

Elizabeth Spencer
Office of Research on Women’s Health/Office of the Director (ORWH/OD)
Telephone: 301-435-1057
Email: Elizabeth.spencer@nih.gov

Kim Stanton
National Health Lung and Blood Institute (NHLBI) (All of Us Research Program/Office of the Director (AoURP/OD))
Telephone: 301-827-8054
Email: stantonk@mail.nih.gov

Thuthuy Nguyen
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
301-594-8825
thuthuynguyen@niddk.nih.gov

Theresa Jarosik
National Institute of Mental Health (NIMH)
Telephone: 301-443-3858
Email: Theresa.Jarosik@nih.gov

Shelley Carow
National Center for Complementary and Integrative Health (NCCIH)
Telephone: 301-594-3788
Email: CarowS@mail.nih.gov